Join more than 1,300 vascular access professionals who will attend the AVA 2015 Annual Scientific Meeting.
This four day meeting will provide you with opportunities to participate in educational sessions, hands-on training, and new product demonstrations, and lots of networking!
More than 1,400 attendees are expected at the Gaylord Texan Resort and Convention Center from September 26-29, 2015. There will be four days of clinical educational sessions, motivational keynote speakers, networking opportunities and an exhibit hall.
More than 65 exhibitors exhibit at AVA - the premier conference for vascular access clinicians & healthcare professionals. Companies that provide products listed below should exhibit at AVA 2015.
Alternate Site Infusion
Catheter Position Systems
Catheter Stabilization Devices
Central Line Maintenance
Custom Kits & Trays
Drug Delivery Filters
Home Care Infusion
Infection Prevention Products
Infusion Medication and Solutions
Infusion Site Preparation
PICC Prep solutions
Vein Illumination Devices
More than 900 clinical vascular access professionals will be there! Complimentary post-show attendee list is given to all exhibitors.
Vendors can be attendees too! Exhibitors receive additional opportunities to interact with conference attendees through vendor access to ALL educational sessions.
Give your clients and potential customers hands-on access to your current and new products and devices.
Ensure that your company name and products are remembered by vascular access professionals by keeping your name and products in front of them at all times.
Learn what new issues the vascular industry clinicians are facing in the field. Discover their concerns and how you can help resolve their problems.
The Association for Vascular Access (AVA) is an association of healthcare professionals founded in 1985 to promote the emerging vascular access specialty. Today, its multidisciplinary membership advances research, provides professional and public education to shape practice and enhance patient outcomes, and partners with the device manufacturing community to bring about evidence-based innovations in vascular access.